Summers Value Partners’ Update on Journey Medical (DERM)
Summers Value Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Journey Medical Corp (DERM)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 1,854,596 | $13,315,999 | 0.67% | |
| 2. | Renaissance Technologies Jim Simons | 243,500 | $1,748,330 | +3% | 0% |
| 3. | Opaleye Management James A. Silverman | 95,000 | $682,100 | +38% | 0.14% |
| 4. | Pale Fire Capital Dusan Senkypl, David Holy, And Jan Barta | 32,458 | $233,048 | +20% | 0.02% |
| 5. | Millennium Management Israel Englander | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.04 | 10,000 | $30,400.00 | 144,245 | 2024-03-25 | Filing | |
| $3.48 | 10,000 | $34,790.00 | 2,163,430 | 2024-03-22 | Filing | |
| $3.47 | 30,000 | $104,100.00 | 134,717 | 2024-03-22 | Filing | |
| $3.40 | 20,000 | $68,000.00 | 134,245 | 2024-03-22 | Filing | |
| $2.98 | 33,000 | $98,340.00 | 104,717 | 2023-10-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.84 | 4,834 | $33,064.56 | 2,348,313 | 2025-05-02 | Filing | |
| $6.84 | 2,409 | $16,477.56 | 203,557 | 2025-05-02 | Filing | |
| $6.84 | 2,857 | $19,541.88 | 504,817 | 2025-05-02 | Filing | |
| $5.01 | 49,271 | $246,847.71 | 2,003,147 | 2025-03-11 | Filing | |
| $5.01 | 14,905 | $74,674.05 | 2,052,418 | 2025-03-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 132,904 | $946,276 | 0.61% | |
| 2. | 16,842 | $119,916 | 0% | |
| 3. | 15,000 | $106,800 | 0.01% | |
| 4. | 12,100 | $86,152 | 0% | |
| 5. | 164 | $1,168 | 0% |
News See All
Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript August 12, 2025Journey Medical Corporation misses on earnings expectations.
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2025 Financial Results and Corporate Update Conference Call.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
10 Cheap Hot Stocks to Buy Right Now
Periods of high market volatility can make cheap stocks attractive because sharp price swings may undervalue fundamentally strong growth companies in the short run.
Journey Medical Corporation (NASDAQ:DERM) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (DERM): A Bull Case Theory
We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM.
Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the same can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good day, and welcome to Journey Medical's Second Quarter 2024 Financial Results and Corporate Update Conference Call.
Journey Medical Corporation (NASDAQ:DERM) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2024 Financial Results and Corporate Update Conference Call.
Hedge Fund Resource Center Billionaire Hedge Funds
